Filtered By:
Source: Europace

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 183 results found since Jan 2013.

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
Conclusion Among oral anticoagulation-naïve AF patients initiated on oral anticoagulation in Denmark, warfarin initiation has declined since the introduction of dabigatran in August 2011. Dabigatran is the most frequently used alternative option to warfarin; however, use of rivaroxaban and apixaban is increasing. Patients initiated with rivaroxaban or apixaban in general have a higher predicted stroke and bleeding risks compared with warfarin or dabigatran initiators.
Source: Europace - January 29, 2015 Category: Cardiology Authors: Olesen, J. B., Sorensen, R., Hansen, M. L., Lamberts, M., Weeke, P., Mikkelsen, A. P., Kober, L., Gislason, G. H., Torp-Pedersen, C., Fosbol, E. L. Tags: Atrial fibrillation Source Type: research

A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Conclusion Screening of silent AF by intermittent ECG recordings in patients with a recent ischaemic stroke is a cost-effective use of health care resources saving costs and lives and improving the quality of life.
Source: Europace - January 29, 2015 Category: Cardiology Authors: Levin, L.-A., Husberg, M., Sobocinski, P. D., Kull, V. F., Friberg, L., Rosenqvist, M., Davidson, T. Tags: Atrial fibrillation Source Type: research

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation
Conclusion The EORP-AF Pilot survey provides contemporary data on sex differences in clinical features and management of AF patients participating in the EORP-AF Pilot registry. Female subjects were older and more symptomatic, compared with males, and were more likely to receive rate control. Also, female patients were at higher stroke risk overall, but oral anticoagulation was used in a high proportion of patients.
Source: Europace - December 31, 2014 Category: Cardiology Authors: Lip, G. Y. H., Laroche, C., Boriani, G., Cimaglia, P., Dan, G.-A., Santini, M., Kalarus, Z., Rasmussen, L. H., Popescu, M. I., Tica, O., Hellum, C. F., Mortensen, B., Tavazzi, L., Maggioni, A. P. Tags: Atrial fibrillation Source Type: research

Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?
Conclusion Despite the high specificity, AF diagnosis in the Swedish Patient Register assessed in the population of ischaemic stroke patients and age- and gender-matched control subjects has modest sensitivity, which may result in underestimating prevalent and incident AF cases if only register data are used for identification of subjects with AF in epidemiology studies.
Source: Europace - November 22, 2014 Category: Cardiology Authors: Baturova, M. A., Lindgren, A., Carlson, J., Shubik, Y. V., Bertil Olsson, S., Platonov, P. G. Tags: Atrial fibrillation Source Type: research

Visually guided laser ablation: a single-centre long-term experience
Conclusion Our single-centre experience using VGLA over 4 years shows that it can be used safely and effectively in normal clinical practice and gives high levels of acute PVI accompanied by good clinical outcomes, even after long-term follow-up.
Source: Europace - November 22, 2014 Category: Cardiology Authors: Šediva, L., Petrů, J., Škoda, J., Janotka, M., Chovanec, M., Reddy, V., Neužil, P. Tags: Ablation for atrial fibrillation Source Type: research

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
Conclusion Using interrupted OAC, low target intraprocedural ACT, and irrigated-tip RF, the rate of peri-procedural groin, haemorrhagic, and thromboembolic complications was extremely low. There were only minimal differences between OACs. Low-risk patients may remain on aspirin/no OAC pre-ablation. There are no problems changing from one OAC pre-ablation to another post-ablation.
Source: Europace - September 29, 2014 Category: Cardiology Authors: Winkle, R. A., Mead, R. H., Engel, G., Kong, M. H., Patrawala, R. A. Tags: Ablation for atrial fibrillation Source Type: research

A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention
Conclusion When optimal programming is utilized, inappropriate shocks are rare in primary prevention patients with both single- and dual-chamber ICDs. The routine use of dual-chamber ICDs increases the expense without reducing inappropriate shocks or improving the quality of life at 1 year. Trial Registration clinicaltrials.gov Identifier: NCT00787800.
Source: Europace - September 29, 2014 Category: Cardiology Authors: Friedman, P. A., Bradley, D., Koestler, C., Slusser, J., Hodge, D., Bailey, K., Kusumoto, F., Munger, T. M., Militanu, A., Glikson, M. Tags: Sudden death and ICDs Source Type: research

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
Conclusion The high AF detection performance of the MyDiagnostick, combined with the ease of use of the device, enables large screening programmes for detection of undiagnosed AF.
Source: Europace - August 29, 2014 Category: Cardiology Authors: Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., Houben, R. P. Tags: Atrial fibrillation Source Type: research

The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation
Conclusion The majority of LAAC costs are borne in the first year, while costs for pharmaceutical strategies continue to accrue year on year. Thus, LAAC represents an opportunity for savings to healthcare systems in the long term. This is an important consideration for payers in evaluating lifetime treatment strategies in AF.
Source: Europace - July 29, 2014 Category: Cardiology Authors: Amorosi, S. L., Armstrong, S., Da Deppo, L., Garfield, S., Stein, K. Tags: Atrial fibrillation Source Type: research

Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?
Source: Europace - May 5, 2014 Category: Cardiology Authors: Lau, Y. C., Lip, G. Y. H. Tags: EDITORIALS Source Type: research

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion
This article is a summary of the Third Global Summit on LAA occlusion, 15 March 2013, Barcelona, Spain.
Source: Europace - May 5, 2014 Category: Cardiology Authors: Lewalter, T., Kanagaratnam, P., Schmidt, B., Rosenqvist, M., Nielsen-Kudsk, J. E., Ibrahim, R., Albers, B. A., Camm, A. J. Tags: REVIEW Source Type: research

Atrial fibrillation patients do not benefit from acetylsalicylic acid
Conclusion Acetylsalicylic acid as monotherapy in stroke prevention of atrial fibrillation has no discernable protective effect against stroke, and may even increase the risk of ischaemic stroke in elderly patients. Thus, our data support the new European guidelines recommendation that ASA as monotherapy should not be used as stroke prevention in atrial fibrillation.
Source: Europace - May 5, 2014 Category: Cardiology Authors: Sjalander, S., Sjalander, A., Svensson, P. J., Friberg, L. Tags: Atrial fibrillation Source Type: research

Stroke and bleeding risk evaluation in atrial fibrillation: results of the European Heart Rhythm Association survey
The aim of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke and bleeding risk evaluation in atrial fibrillation, particularly regarding the use of risk evaluation schemes, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of these risk assessment schemes. There were some obvious practice differences. However, reassuring information on current practice in Europe was evident, but more focus on renal function is warranted, especially facing the fact that ...
Source: Europace - May 5, 2014 Category: Cardiology Authors: Larsen, T. B., Potpara, T., Dagres, N., Pison, L., Estner, H., Blomstrom-Lundqvist, C., Scientific Initiative Committee, European Heart Rhythm Association, Blomstrom-Lundqvist, Bongiorni, Chen, Dagres, Estner, Hernandez-Madrid, Hocini, Larsen, Pison, Potp Tags: EP WIRE Source Type: research

Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study
Conclusion Active IBD is associated with increased risk of AF and stroke. These findings may be relevant to clinical practice.
Source: Europace - April 7, 2014 Category: Cardiology Authors: Kristensen, S. L., Lindhardsen, J., Ahlehoff, O., Erichsen, R., Lamberts, M., Khalid, U., Torp-Pedersen, C., Nielsen, O. H., Gislason, G. H., Hansen, P. R. Tags: Atrial fibrillation Source Type: research

Morphological features of the P-waves at surface electrocardiogram as surrogate to mechanical function of the left atrium following a successful modified maze procedure
Conclusion Absent LA mechanical contraction following the modified maze operation may be accompanied by a distinguished pattern of the P-waves on the surface ECG.
Source: Europace - April 7, 2014 Category: Cardiology Authors: Buber, J., Luria, D., Sternik, L., Kuperstein, R., Grupper, A., Goldenberg, I., Raanani, E., Feinberg, M. S., Nof, E., Eldar, M., Glikson, M. Tags: Electrocardiology and risk stratification Source Type: research